Phase I Clinical Trial of Recombinant Humanized Anti-vegf Monoclonal Antibody Single Vitreous Injection for Safety, Tolerance, PK and Pharmacodynamics in nAMD Patients
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions
Most Recent Events
- 09 Nov 2018 New trial record